Background: Microcystic macular changes, also called microcystic macular oedema (MMO), have recently been reported in patients with multiple sclerosis (MS), particularly after optic neuritis. But it has since emerged that the finding is not specific for optic neuritis. This study was designed to prospectively investigate the prevalence of microcystic perifoveal changes in patients with optic atrophy not due to optic neuritis.
INTRODUCTION
Recently, a new phenomenon of optical coherence tomography (OCT) imaging of the perifoveal region of the retina has been reported, with microcystic like changes in the inner nuclear layer (INL). [1] The term 'microcystic macular oedema (MMO)' was coined, [1] and subsequently translated to US spelling 'edema' as MME. [2] This new phenomenon drew a lot of attention in the neurological literature. Importantly, the microcystic changes were described in the retina of patients suffering from multiple sclerosis (MS) and were related to clinical and radiological disease activity. [1, 3] The rapid recognition that these microcystic changes were not specific for MS stimulated an extensive exchange of letters. [4] [5] [6] [7] Notably, microcystic changes were also seen in patients with non-MS types of optic neuritis, such as relapsing isolated optic neuritis (RION), [4] chronic relapsing optic neuropathy (CRION), [8, 9] neuromyelitis optica ON (NMO-ON), [8] as well as aetiologies other then optic neuritis (ON). [5] [6] [7] [10] [11] [12] [13] [14] It has also become apparent that microcystic macular changes occurred in ophthalmological degenerative diseases like age-related macular degeneration, diabetic retinopathy, vascular occlusion and with epiretinal membranes. [14, 15] As the etiology of this retinal abnormality remains unknown and evidence for oedema not conclusively been provided, Kisimby et al. (2013) suggested to be careful about the terminology. [11] Therefore Abegg et al proposed to refer to a "retrograde maculopathy". [13] Kisimbi et al. (2013) were also first to report that infrared imaging (IR) may be a convenient method to demonstrate the localisation of microcystic changes in the retina. [11] This has since been confirmed and scanning laser ophthalmoscopy (SLO) was added to the list more recently. [8, 10, 12, 13] Taken together these imaging modalities consistently describe the microcysts to be distributed in a circular area, or semicircular area around the fovea. [8, [10] [11] [12] [13] 16] An important limitation of all these observations was the retrospective study design resulting in a large variation of the reported prevalence, ranging from 0.8% to 25%. [3] [4] [5] [6] [7] [8] [10] [11] [12] [13] [14] [15] In addition, there has been an inclusion bias towards ON and a publication bias of the neurological literature with the true clinical spectrum being much broader. [15] Therefore, the present study was designed to prospectively investigate the prevalence and epidemiology of microcystic paramacular changes in patients who did not suffer from ON and close the gap between the neurological and ophthalmological literature.
METHODS

Study design and patient population
Patient and controls were enrolled at two Dutch university medical centres (Groningen, Amsterdam), between May 2013 and April 2014 for this cross-sectional study. The study was approved by the medical ethical committees and the scientific research committee at both centres. Written informed consent was obtained from all patients included.
Patients were prospectively recruited either by referral to our tertiary care neuroophthalmology service or own follow-ups.
Inclusion criteria: All patients were older then 18 years of age, and had a history of optic nerve atrophy.
Exclusion criteria: optic neuritis due to multiple sclerosis (MSON), isolated optic neuritis (ION), relapsing isolated optic neuritis (RION), chronic relapsing inflammatory optic neuropathy (CRION), optic neuritis due to neuromyelitis optica (NMO-ON) and
Harding's disease. An onset of optic atrophy of less then 4 months ago after AION, because of possible presence of subretinal oedema. We also excluded cases with intraocular surgery in the past 6 months, previous radiotherapy to the visual pathways, diabetes mellitus, macular degeneration, retinal vein occlusion, retinal dystrophy, uveitis or retinal detachment.
Clinical assessment: Demographic data and the medical history were obtained in all patients. Snellen visual acuities (VA) were recorded using high contrast charts.
Spectral domain optical coherence tomography (SD OCT)
Two SD OCT devices were used, a Canon OCT -HS100 in Groningen and a Heidelberg Spectralis in Amsterdam. Bot devices have a build in scanning laser ophthalmoscopy (SLO) camera and the eye tracking function was enabled as required for accurate quantitative OCT data assessment by maintaining eye alignment during image recording.
In Groningen, multi-cross high resolution scans were made in horizontal and vertical direction through the macular area. In order to include the whole macular area, multicross scans were made with a scan size of 3x3 mm and 10x10mm. We used a low averaging mode of 5 scans only, because in our experience these microcysts can be so small that they can be averaged out from the summary image. Furthermore, a macular volume scan was made (10x10 mm), and a 3D scan of the optic disc area (6x6 mm), including an about 3.45 mm ringscan of the peripapillary retinal nerve fibre layer (pRNFL). The multicross scans and the macular volume scans were analysed for the presence of so-called MMO using validated criteria. [14] The quantitative pRNFL data served to grade the degree of optic atrophy seen by funduscopy. The normative database of the Canon OCT-HS100 was used for this purpose. The OCT scan divides the circle into four quadrants (temporal, superior, nasal, inferior) and gives the RNFL thickness for these sectors. For each eye, we calculated the mean value of these four quadrants to get an average RNFL thickness.
Likewise, in Amsterdam, an about 3.4 mm peripapillary ringscan was performed as well as two volume scans with vertically orientated OCT B-scans of a 20x20 degree field (25 sections) for the macular and a 15 x 15 degrees field (73 sections) for the optic nerve head.
Statistical analyses
All statistical analyses were done in SPSS (version 22) and SAS (version 9.2). Normal distribution was checked graphically and using Shapiro-Wilk statistics. Normally distributed data were presented as mean and standard deviation (SD) and non-Gaussian data as median and interquartile range (IQR). Parametric and non-parametric testing was used according to normality. Categorical data were compared using the Fisher exact test.
RESULTS
Fifty-four patients were included with a mean age of 46.5 years (range 18 to 79 years).
Twenty-four (44.4%) were female and twenty-eight (55.6%) male. Almost all patient were recruited by one centre (Groningen, n=52). The ethnic background was Caucasian in 52, Asian in one, and Arabic in another patient.
In all patients both eyes were imaged by SLO and OCT. Optic atrophy was binocular in 37/54 (68.5%) patients and monocular in 17/54 (31.5%) patients. In all cases a pale disc on funduscopy corresponded to a pathological degree of pRNFL thinning. Table 1 summarises the aetiologies of optic atrophy in this study. The number of patients with microcystic macular changes in the different etiologic subgroups is also given.
Microcystic changes were seen in 11/54 patients (20.4%). Considering individual eyes, microcystic changes were present in 17/90 eyes (18.9%) with optic atrophy. In four 3) . The other three patients had a monocular optic atrophy. Importantly, microcystic changes were never seen in absence of optic atrophy. There was one patient with bilateral microcystic changes and only a unilateral AION. A follow-up investigation revealed presence of burried optic disc drusen in the presumed healthy eye. This eye also showed a segmental thinning of the pRNFL on OCT. We rated this patient as having a binocular optic neuropathy.
OCT and SLO images
Examples of OCT scans with microcystic macular changes together with SLO images are shown in figures 1-3. Figure 1 is the OCT and SLO image of the right and left eye of a 24 years old patient who experienced a traumatic optic neuropathy of his left eye 10 month earlier. The OCT image of his right eye ( Fig 1A) shows an intact RNFL (filled white arrow) at site of the inferior optic disc ( Fig 1B) . The OCT of the left eye ( Interestingly, hyperreflective dots were also seen in the INL far beyond the area of visible microcystic changes. A vertical OCT cross-section through the macular area is shown in the insert (Fig 1 F) . The SLO image of the left eye (Fig 1 E) shows a C-shaped dark ring representing the area where the MMO was present on the OCT imaging. 
Correlation with age and disease duration
There was no significant difference in the mean age between the patients without (46. Figure 4 shows box plot of the mean pRNFL thickness in the normal eyes of patients with monocular optic atrophy, the eyes with optic atrophy, but without microcystic macular changes and the eyes with microcystic macular changes. The groups were unbalanced and the data not Gaussian. General linear models showed a significant difference between groups (F2,89=46.01, p<0.0001) with a significant degree of atrophy in both groups (p<0.0001 for both, Fig 4) but no difference between those with and without microcystic changes.
Correlation with RNFL measurement
DISCUSSION
The main outcome of this prospective study was that microcystic macular changes were present in 20.4% of the patients with optic atrophy not due to optic neuritis. At first sight this appears to be substantially more compared to the pooled prevalence of 7.7%
reported by . [6] Of note, the averaged disease duration was shorter in the Abegg study with 6.5 years compared to the 16 years in the present study. It is possible that the prevalence of microcystic changes might be higher with longstanding otpic atrophy, but prospective longitudinal data will be required to test this. The presence of microcystic changes in the context of hydrocephalus as described in one of our patients is consistent with another recent report on bilateral microcystic changes in a child with bilateral optic atrophy due to hydrocephalus (see Figure 5 in Tawse et al.
(2014)). [18] From a clinical practice point of view it is relevant that microcystic macular changes are much more frequent with compressive aetiologies as compared to a recent episode of multiple sclerosis associated optic neuritis (MSON) 4.7-6.3%. [1, 8] The literature on other conditions is only emerging, but it might be prudent to consider neuroimaging if metabolic and heriditary conditions have been excluded and there is no other obvious ophthalmogical explanation. [5, 11, 14, 15] There is clearly a need for future studies to longitudinally investigate the temporal and spatial profile of microcystic changes. Do microcystic changes appear earlier than for example the two to three months it takes for optic atrophy to develop after optic neuritis? Does the longitudinal profile help with the differential diagnosis of inflammatory and compressive pathologies? Does their spatial distribution change over time? There are no data at present to answer any of these pertinent questions.
In the present study there was no difference in the mean age of patients with and without microcystic changes. This is in contrast with the study of where they found that younger patients had a significant higher chance of having microcystic changes then older patients. [13] In our view it is difficult to attribute this to age alone and future prospective studies addressing this question will need to be careful to avoid an inclusion bias due to the age distribution of various aetiologies. Hopkins group to develop an automated algorithm which possibly more accurately describes the spatial resolution of these microcystic changes. [20] It is therefore intriguing to note that microcystic changes were also not necessarily visible on all OCT B-scans were the focally darkened SLO image suggested their possible spatial distribution.
A specific feature of SLO is the high degree of spatial sensitivity which makes it a good tool to identify areas with possible MMO. In addition, the spread areas of abnormal reflections on SLO imaging suggests that the degenerative changes might not be limited to the perifoveolar area. This is supported by another observation made in this study and shown in figure 3 where microcystic changes were detected just outside the perifoveolar area because of a serendipitous eccentric OCT scan in a patient who was not able to fixate. This is an area which is not routinely included in macular OCT
imaging.
The precise nature of the microcystic changes remains unknown. There have been no studies correlating OCT findings with histology. There are, however earlier histological observations which clearly demonstrate retinal vacuoles in the inner nuclear layer of the retina. [21, 22] Retrograde axonal degeneration was the most probable mechanism in the macaccae model. An alternative mechanism, inflammation, was proposed with the recent OCT driven rediscovery of these microcystic changes in patients with MS. [1] [2] [3] But several studies have shown that there was no dye leakage on fluorescein angiography. [5, 10] The data of the present study are more in keeping with the neurodegenerative hypothesis because inflammation was excluded and the long disease duration of 16 years. We and others have therefore drawn an analogy to the appearance of lesions on magnetic resonance imaging, appearing either as a T1 black hole representing neurodegeneration or a T2 lesion representing inflammation. [23] It has also been suggested that retrograde axonal degeneration influences the integrity of the retinal organisation and that loss of retinal Müller cell function may play a role in microcyst formation. [4, 10, 13, 14, 24] Finally, vitreo-retinal traction can lead to the formation of microcystic changes, [5, 7] but certainly does not represent an unifying mechanism because it has conclusively shown to be absent in a number of cases. [25] Taken together, the present study is the first prospective report on the prevalence of microcystic changes in patients with optic atrophy. The data show that microcystic changes are a frequent phenomena, particularly in the context of optic atrophy. It is important for ophthalmologists to recognise these macular changes because they can be the result by pathology remotely located from the macula. Presence of microcystic macular changes should trigger pertinent questions and in absence of a history for optic neuritis or another evident aetiology one should consider imaging of the brain and orbits. 
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